Katayama, Y.; Akioka, T.; Kimura, S.; Fujii, M.; Nagai, T.; Kiwaki, T.; Kawaguchi, M.; Fukushima, T.; Sato, Y.; Mukai, S.;
et al. Engineered Expression of Hepatocyte Growth Factor Activator Inhibitor-1 (HAI-1) Reduces the Growth of Bladder Cancer Cells. Biomedicines 2025, 13, 871.
https://doi.org/10.3390/biomedicines13040871
AMA Style
Katayama Y, Akioka T, Kimura S, Fujii M, Nagai T, Kiwaki T, Kawaguchi M, Fukushima T, Sato Y, Mukai S,
et al. Engineered Expression of Hepatocyte Growth Factor Activator Inhibitor-1 (HAI-1) Reduces the Growth of Bladder Cancer Cells. Biomedicines. 2025; 13(4):871.
https://doi.org/10.3390/biomedicines13040871
Chicago/Turabian Style
Katayama, Yuichi, Takahiro Akioka, Shoichi Kimura, Masato Fujii, Takahiro Nagai, Takumi Kiwaki, Makiko Kawaguchi, Tsuyoshi Fukushima, Yuichiro Sato, Shoichiro Mukai,
and et al. 2025. "Engineered Expression of Hepatocyte Growth Factor Activator Inhibitor-1 (HAI-1) Reduces the Growth of Bladder Cancer Cells" Biomedicines 13, no. 4: 871.
https://doi.org/10.3390/biomedicines13040871
APA Style
Katayama, Y., Akioka, T., Kimura, S., Fujii, M., Nagai, T., Kiwaki, T., Kawaguchi, M., Fukushima, T., Sato, Y., Mukai, S., Kamoto, T., & Sawada, A.
(2025). Engineered Expression of Hepatocyte Growth Factor Activator Inhibitor-1 (HAI-1) Reduces the Growth of Bladder Cancer Cells. Biomedicines, 13(4), 871.
https://doi.org/10.3390/biomedicines13040871
